SEC Form 4 · accession 0001144204-17-048486
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Fourteau
Officer — President and CEO · Director
Period of report
Sep 15, 2017
Accepted (ET)
Sep 18, 2017 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2,F1 | $0.32 | Sep 15, 2017 | A | 5,000 | A | — | Sep 15, 2027 | Common | 5,000 | 5,000 | D |
Explanation of responses
- F1Option shares shall vest in equal monthly installments over the first twelve months after the date of grant.
- F2Received as compensation for service on Board of Directors of issuer.